Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 229

    1.

    Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

    Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Engelgau MM.

    Diabetes Care. 2007 Nov;30(11):2874-9. Epub 2007 Aug 13.PMID: 17698614 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Screening for type 2 diabetes: literature review and economic modelling.

    Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

    Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.PMID: 17462167 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

    Eddy DM, Schlessinger L, Kahn R.

    Ann Intern Med. 2005 Aug 16;143(4):251-64.PMID: 16103469 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations]

    Flórez H.

    Invest Clin. 1997 Mar;38(1):39-52. Review. Spanish. PMID: 9235072 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults: response to Hoerger et al.

    Wechowski JW.

    Diabetes Care. 2008 May;31(5):e34; author reply e35. No abstract available. PMID: 18445714 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.

    Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group.

    Ann Intern Med. 2005 Mar 1;142(5):323-32.PMID: 15738451 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies.

    Zhang P, Engelgau MM, Valdez R, Benjamin SM, Cadwell B, Narayan KM.

    Diabetes Care. 2003 Sep;26(9):2536-42.PMID: 12941715 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention.

    Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM.

    Diabetes Care. 2003 Mar;26(3):645-9.PMID: 12610015 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Modelling the lifetime costs and health effects of lifestyle intervention in the prevention and treatment of obesity in Switzerland.

    Galani C, Schneider H, Rutten FF.

    Int J Public Health. 2007;52(6):372-82.PMID: 18369000 [PubMed - indexed for MEDLINE]Related articles

    10.

    Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.

    Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, Davies MJ, Khunti K.

    BMJ. 2008 May 24;336(7654):1180-5. Epub 2008 Apr 21.PMID: 18426840 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.

    Hu D, Hook EW 3rd, Goldie SJ.

    Ann Intern Med. 2004 Oct 5;141(7):501-13. Erratum in: Ann Intern Med. 2004 Nov 2;141(9):744. PMID: 15466767 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.

    Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M.

    Ann Intern Med. 2004 May 4;140(9):689-99.PMID: 15126252 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Visual screening for malignant melanoma: a cost-effectiveness analysis.

    Losina E, Walensky RP, Geller A, Beddingfield FC 3rd, Wolf LL, Gilchrest BA, Freedberg KA.

    Arch Dermatol. 2007 Jan;143(1):21-8.PMID: 17224538 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Cost-effectiveness of type 2 diabetes screening: results from recently published studies.

    Icks A, Rathmann W, Haastert B, John J, Löwel H, Holle R, Giani G; KORA Study Group.

    Gesundheitswesen. 2005 Aug;67 Suppl 1:S167-71.PMID: 16032536 [PubMed - indexed for MEDLINE]Related articles

    15.

    Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.

    Diabetes Prevention Program Research Group.

    Diabetes Care. 2003 Sep;26(9):2518-23.PMID: 12941712 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes.

    Ackermann RT, Marrero DG, Hicks KA, Hoerger TJ, Sorensen S, Zhang P, Engelgau MM, Ratner RE, Herman WH.

    Diabetes Care. 2006 Jun;29(6):1237-41.PMID: 16732002 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.

    Hutton DW, Tan D, So SK, Brandeau ML.

    Ann Intern Med. 2007 Oct 2;147(7):460-9.PMID: 17909207 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study.

    Jacobs-van der Bruggen MA, Bos G, Bemelmans WJ, Hoogenveen RT, Vijgen SM, Baan CA.

    Diabetes Care. 2007 Jan;30(1):128-34.PMID: 17192345 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Prediabetes and its relationship with obesity in Mexican adults: The Mexican Diabetes Prevention (MexDiab) Study.

    Guerrero-Romero F, Rodríguez-Morán M, Pérez-Fuentes R, Sánchez-Guillén MC, González-Ortiz M, Martínez-Abundis E, Brito-Zurita O, Madero A, Figueroa B, Revilla-Monsalve C, Flores-Martínez SE, Islas-Andrade S, Rascón-Pacheco RA, Cruz M, Sánchez-Corona J.

    Metab Syndr Relat Disord. 2008 Spring;6(1):15-23.PMID: 18370832 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data